ADAMTS-13 is produced by glial cells and upregulated after spinal cord injury

Neurosci Lett. 2012 May 23;517(1):1-6. doi: 10.1016/j.neulet.2012.03.002. Epub 2012 Mar 7.

Abstract

ADAMTS-13, a member of the family of disintegrins and metalloproteinases with thrombospondin motifs, is produced primarily in the liver, particularly by hepatic stellate cells. This metalloproteinase cleaves von Willebrand factor multimers and thereby regulates blood coagulation. Here, we investigated the expression of ADAMTS-13 in the central nervous system. ADAMTS-13 mRNA was expressed in cultured astrocytes and microglia but not in neurons. The protein production of ADAMTS-13 was also detected in these cultured glial cells. Furthermore, we found that the expression of ADAMTS-13 was significantly increased in the rat spinal cord after injury. Supporting the in vivo data, ADAMTS-13 protein was detected in GFAP- and CD11b-positive glial cells in injured spinal cord. Consistent with this, the proteolytic activity of ADAMTS-13 was increased after spinal cord injury. Our data suggest that ADAMTS-13 may have a critical role in the central nervous system, particularly after neuronal injuries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / biosynthesis*
  • ADAM Proteins / genetics
  • ADAMTS13 Protein
  • Animals
  • Astrocytes / cytology
  • Astrocytes / metabolism
  • Cells, Cultured
  • Female
  • Gene Expression Regulation, Enzymologic
  • Glial Fibrillary Acidic Protein / metabolism
  • Neuroglia / cytology
  • Neuroglia / enzymology*
  • Neurons / cytology
  • Neurons / metabolism
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord Injuries / enzymology*
  • Up-Regulation

Substances

  • Glial Fibrillary Acidic Protein
  • RNA, Messenger
  • ADAM Proteins
  • ADAMTS13 Protein
  • Adamts13 protein, rat